Purpose. Special considerations in the selection of medication inhaler devices for elderly patients with chronic obstructive pulmonary disease (COPD) in the ambulatory care setting are reviewed.

A device costing just pennies, based on an idea by a University of Manchester Professor to help his son use an inhaler, could ...

Hydroxychloroquine is under clinical development by PureIMS and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...

On December 20, 2024, the US Court of Appeals for the Federal Circuit released its opinion in Teva Branded Pharm. Prods. R&D, Inc. v. Amneal ...

Vectura Group Limited is a British pharmaceuticals company based in Chippenham, England, which develops inhaled medicines and ...

On December 20, 2024, the U.S. Court of Appeals for the Federal Circuit issued a significant ruling in the Teva v.

Teva has launched a digitally-enabled inhaler in the UK, the first European market for the device, for use by patients with asthma and chronic obstructive pulmonary disorder (COPD). The GoResp ...

Like many parents of asthmatic children, Tariq Aslam found it incredibly difficult to watch his young son struggling to cope ...

A device costing just pennies, based on an idea by a University of Manchester Professor to help his son use an inhaler, could be a gamechanger for asthma patients. The impressive results are from ...